281 related articles for article (PubMed ID: 35334916)
1. Mediterranean Diet: A Tool to Break the Relationship of Atrial Fibrillation with the Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease.
Biccirè FG; Bucci T; Menichelli D; Cammisotto V; Pignatelli P; Carnevale R; Pastori D
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334916
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
[TBL] [Abstract][Full Text] [Related]
3. Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features.
Bullón-Vela V; Abete I; Tur JA; Pintó X; Corbella E; Martínez-González MA; Toledo E; Corella D; Macías M; Tinahones F; Fitó M; Estruch R; Ros E; Salas-Salvadó J; Daimiel L; Zulet MA; Martínez JA;
Nutrition; 2020 Mar; 71():110620. PubMed ID: 31838461
[TBL] [Abstract][Full Text] [Related]
4. Association between Non-Alcoholic Fatty Liver Disease and Mediterranean Lifestyle: A Systematic Review.
Mascaró CM; Bouzas C; Tur JA
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010923
[TBL] [Abstract][Full Text] [Related]
5. Mediterranean diet and non-alcoholic fatty liver disease: new therapeutic option around the corner?
Sofi F; Casini A
World J Gastroenterol; 2014 Jun; 20(23):7339-46. PubMed ID: 24966604
[TBL] [Abstract][Full Text] [Related]
6. The association of non-alcoholic fatty liver disease and atrial fibrillation: a review.
Käräjämäki AJ; Hukkanen J; Ukkola O
Ann Med; 2018 Aug; 50(5):371-380. PubMed ID: 29929399
[TBL] [Abstract][Full Text] [Related]
7. The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis.
Wijarnpreecha K; Boonpheng B; Thongprayoon C; Jaruvongvanich V; Ungprasert P
Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):525-532. PubMed ID: 28866089
[TBL] [Abstract][Full Text] [Related]
8. Cardiometabolic risk factors and atrial fibrillation.
Menezes AR; Lavie CJ; Dinicolantonio JJ; O'Keefe J; Morin DP; Khatib S; Abi-Samra FM; Messerli FH; Milani RV
Rev Cardiovasc Med; 2013; 14(2-4):e73-81. PubMed ID: 24448257
[TBL] [Abstract][Full Text] [Related]
9. Impact of Nonalcoholic Fatty Liver Disease on Arrhythmia Recurrence Following Atrial Fibrillation Ablation.
Donnellan E; Cotter TG; Wazni OM; Elshazly MB; Kochar A; Wilner B; Patel D; Kanj M; Hussein A; Baranowski B; Cantillon D; Griffin B; Jaber W; Saliba WI
JACC Clin Electrophysiol; 2020 Oct; 6(10):1278-1287. PubMed ID: 33092755
[TBL] [Abstract][Full Text] [Related]
10. Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review.
Coronati M; Baratta F; Pastori D; Ferro D; Angelico F; Del Ben M
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334784
[TBL] [Abstract][Full Text] [Related]
11. Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease?
Plaz Torres MC; Bodini G; Furnari M; Marabotto E; Zentilin P; Giannini EG
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33139607
[TBL] [Abstract][Full Text] [Related]
12. Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
Kang MK; Park JG; Kim MC
Yonsei Med J; 2020 Oct; 61(10):860-867. PubMed ID: 32975060
[TBL] [Abstract][Full Text] [Related]
13. Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development.
Vancells Lujan P; Viñas Esmel E; Sacanella Meseguer E
Nutrients; 2021 Apr; 13(5):. PubMed ID: 33923255
[TBL] [Abstract][Full Text] [Related]
14. Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease.
El Hadi H; Di Vincenzo A; Vettor R; Rossato M
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31064058
[TBL] [Abstract][Full Text] [Related]
15. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.
Zhang Y; Zhang T; Zhang C; Tang F; Zhong N; Li H; Song X; Lin H; Liu Y; Xue F
BMJ Open; 2015 Sep; 5(9):e008204. PubMed ID: 26395497
[TBL] [Abstract][Full Text] [Related]
16. Prevention and Treatment of Atrial Fibrillation via Risk Factor Modification.
O'Keefe EL; Sturgess JE; O'Keefe JH; Gupta S; Lavie CJ
Am J Cardiol; 2021 Dec; 160():46-52. PubMed ID: 34583808
[TBL] [Abstract][Full Text] [Related]
17. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study.
Abenavoli L; Greco M; Milic N; Accattato F; Foti D; Gulletta E; Luzza F
Nutrients; 2017 Aug; 9(8):. PubMed ID: 28805669
[TBL] [Abstract][Full Text] [Related]
18. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies.
Marventano S; Salomone F; Godos J; Pluchinotta F; Del Rio D; Mistretta A; Grosso G
Clin Nutr; 2016 Dec; 35(6):1269-1281. PubMed ID: 27060021
[TBL] [Abstract][Full Text] [Related]
19. Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?
Katsiki N; Perez-Martinez P; Anagnostis P; Mikhailidis DP; Karagiannis A
Curr Vasc Pharmacol; 2018; 16(3):219-227. PubMed ID: 28669328
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes.
Targher G; Mantovani A; Pichiri I; Rigolon R; Dauriz M; Zoppini G; Morani G; Vassanelli C; Bonora E
Clin Sci (Lond); 2013 Sep; 125(6):301-9. PubMed ID: 23596966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]